Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

BAY-2402234

Catalog No. T14501Cas No. 2225819-06-5

BAY-2402234 is an inhibitor of dihydroorotate dehydrogenase (DHODH) for the treatment of myeloid malignancies.BAY 2402234 is a selective low-nanomolar inhibitor of human DHODH enzymatic activity.

BAY-2402234

BAY-2402234

Purity: 98.90%
Catalog No. T14501Cas No. 2225819-06-5
BAY-2402234 is an inhibitor of dihydroorotate dehydrogenase (DHODH) for the treatment of myeloid malignancies.BAY 2402234 is a selective low-nanomolar inhibitor of human DHODH enzymatic activity.
Pack SizePriceAvailabilityQuantity
1 mg$183In Stock
2 mg$259In Stock
5 mg$387In Stock
10 mg$597In Stock
25 mg$953In Stock
50 mg$1,290In Stock
100 mg$1,730In Stock
1 mL x 10 mM (in DMSO)$446In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "BAY-2402234"

Select Batch
Purity:98.90%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
BAY-2402234 is an inhibitor of dihydroorotate dehydrogenase (DHODH) for the treatment of myeloid malignancies.BAY 2402234 is a selective low-nanomolar inhibitor of human DHODH enzymatic activity.
In vitro
BAY-2402234 induces differentiation of AML cell lines also in a sub-nanomolar to low-nanomolar range which demonstrates the anticipated mode of action in cellular mechanistic assays[1]. BAY-2402234 is a selective low-nanomolar inhibitor of human DHODH enzymatic activity. It potently inhibits proliferation of AML cell lines in the sub-nanomolar to low-nanomolar range in vitro.
In vivo
BAY-2402234 demonstrates potent in vivo anti-tumor effectiveness as a single agent across various AML (acute myeloid leukemia) xenograft models, including subcutaneous, disseminated, and patient-derived (PDX) forms. It promotes AML cell differentiation, evident through increased differentiation cell surface markers in treated xenograft and PDX models. The engagement of this novel DHODH (dihydroorotate dehydrogenase) inhibitor is confirmed by elevated dihydroorotate levels in tumor tissues and plasma post-treatment. Additionally, transcriptomic analyses reveal differentiation-related changes after a single dose of BAY-2402234, underscoring its mechanistic impact on AML cells[1].
Chemical Properties
Molecular Weight520.84
FormulaC21H18ClF5N4O4
Cas No.2225819-06-5
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 124 mg/mL (238.08 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9200 mL9.5999 mL19.1998 mL95.9988 mL
5 mM0.3840 mL1.9200 mL3.8400 mL19.1998 mL
10 mM0.1920 mL0.9600 mL1.9200 mL9.5999 mL
20 mM0.0960 mL0.4800 mL0.9600 mL4.7999 mL
50 mM0.0384 mL0.1920 mL0.3840 mL1.9200 mL
100 mM0.0192 mL0.0960 mL0.1920 mL0.9600 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BAY-2402234 | purchase BAY-2402234 | BAY-2402234 cost | order BAY-2402234 | BAY-2402234 chemical structure | BAY-2402234 in vivo | BAY-2402234 in vitro | BAY-2402234 formula | BAY-2402234 molecular weight